Nicox (NICXF) OCF Yield %: 0.00 (As of Jul. 01, 2026)


NICXF Nicox SA NICXF
36 GF Score
Price $0.30
GF Value $0.56
! 2 Warning Signs
View Full Analysis

What is Nicox OCF Yield %?

Nicox NICXF 36 OCF Yield % is 0.00 as of Jul. 01, 2026. GuruFocus rates NICXF with a GF Score™ of 36/100 and a GF Value™ of $0.56. The stock has 2 warning signs investors should review. Among 1,415 Biotechnology companies, Nicox ranks worse than 70671.31% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Nicox's Trailing 12-Month Cash Flow from Operations is $0.00 Mil, and Market Cap is $40.18 Mil. Therefore, Nicox's OCF Yield % for today is 0.00%.

The historical rank and industry rank for Nicox's OCF Yield % or its related term are showing as below:


NICXF's OCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -8.19
* Ranked among companies with meaningful OCF Yield % only.

Nicox's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Nicox OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Nicox OCF Yield % Related Terms


Nicox OCF Yield % Historical Data

* Premium members only.

The historical data trend for Nicox's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nicox OCF Yield % Chart

Nicox Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.54 -54.82 0.00 0.00 0.00

Nicox Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NICXF vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Nicox's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nicox OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nicox's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Nicox's OCF Yield % falls into.


NICXF
36GF Score
Nicox SA NICXF
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nicox OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Nicox's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=0 / 26.4393
=0.00%

Nicox's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0 * 2 / 26.4393
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
Nicox (NICXF) has a OCF Yield % of 0.00 as of Jul. 01, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Nicox and its competitors. According to the industry distribution chart, Nicox ranks #999999 out of 1415 companies in the Biotechnology industry.
Is Nicox's OCF Yield % too high?
Nicox's current OCF Yield % is 0.00. Based on the distribution chart, Nicox ranks #999999 out of 1415 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Nicox has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Nicox's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nicox ranks #999999 out of 1415 companies for OCF Yield %. This places Nicox in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Nicox and its competitors. Nicox's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nicox stock overvalued right now?
Nicox (NICXF) has a current OCF Yield % of 0.00. The stock's GF Value™ is $0.56, compared to a current price of $0.30 — trading 46.4% below its estimated fair value. The current OCF Yield % is 0.00. Nicox's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Nicox (NICXF), the current OCF Yield % is 0.00 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nicox (NICXF) Overvalued in 2026?

Based on GuruFocus' analysis, Nicox stock appears to be undervalued. The current stock price of $0.30 is trading 46.4% below its estimated GF Value™ of $0.56.

Key valuation signals for NICXF:

  • OCF Yield %: 0.00
  • GF Value™: $0.56 vs. price of $0.30 (46.4% below fair value)
  • GF Score™: 36/100 with 2 warning signs

No single metric tells the full story. See the NICXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nicox Business Description

Address Rue Evariste Galois, Emerald Square, Batiment C, Sundesk Sophia Antipolis, Biot, FRA, 06410
Nicox SA is an international ophthalmology company developing solutions to help preserve vision and improve ocular health. It is developing a portfolio of treatments targeting glaucoma, diseases of the anterior segment and retinal diseases. A drug candidate (NCX 470) in phase 3 clinical development designed to reduce intraocular pressure ("IOP") in patients with open-angle glaucoma or ocular hypertension. A drug candidate (NCX 1728) in preclinical development for retinal diseases and glaucoma, derived from Nicox's proprietary nitric oxide (NO)-donating research platform. Its products are ZERVIATE, VYZULTA, Naproxcinod, etc.
36GF Score

Get the complete analysis for NICXF

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.30
Price
$0.56
GF Value